Corticosteroid formulations containing sebacate carrier

Corticosteroid formulations in the form of creams, lotions or ointments are provided which are used as anti-inflammatory agents, wherein the corticosteroid, such as halcinonide (21-chloro-9-fluoro-11 beta -hydroxy-16 alpha ,17-[(1-methylethylidene)-bis(oxy)]pregn-4-ene-3,20-dione) is dissolved in a...

Full description

Saved in:
Bibliographic Details
Main Authors HILL, JOHN A, WONG, THOMAS M, WANG, YUANG J
Format Patent
LanguageEnglish
French
German
Published 10.12.1980
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
STEROIDS
Online AccessGet full text

Cover

More Information
Summary:Corticosteroid formulations in the form of creams, lotions or ointments are provided which are used as anti-inflammatory agents, wherein the corticosteroid, such as halcinonide (21-chloro-9-fluoro-11 beta -hydroxy-16 alpha ,17-[(1-methylethylidene)-bis(oxy)]pregn-4-ene-3,20-dione) is dissolved in a sebacate carrier, such as dibutyl sebacate.
Bibliography:Application Number: EP19800301735